IMMUPHARMA PLC (IMM) — research page

UK · uk-cm-kg/AIM/IMM · as of 2026-11-06

Identity and listing

The issuer is IMMUPHARMA PLC, listed on AIM under ticker IMM, with ISIN GB0033711010 and LEI 213800VZKGHXC7VUS895. Its security type is Corporate, its segment is AMSM, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.

The disclosure read

The record holds 25 filings in the twelve months to 2026-11-06, across 22 filing days. The median gap between filing days is 8 days. The latest filing is dated 2026-09-10 and is of type early_warning, and 57 days separate it from the record date of 2026-11-06. The exchange median gap between filing days is 7.0 days and the sector median is 6.0 days. The exchange median filings in the window is 33.5 and the sector median is 42. The exchange median latency is 4 days and the sector median latency is 4.0 days.

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is Crowe U.K. LLP. Its location is not on the record. Auditor changes are not on the record.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record. The market's index does not carry these lifecycle types. The halt flag is listed, not halted.

Orderability

For elective professional client, the outcome is signal ACM-200 and it is determinable. For eligible counterparty, the outcome is signal ACM-200 and it is determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with chapter as of 2026-11-04.

rule acm-68000/uk/product-governance-fca-prod-sourcebook/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The field has not been read. The number of research houses named on the issuer's investor-relations page is not stated.

Open research

The field has not been read. The count of openly published research notes is not stated.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

As-of depth

The market's vintage is not sealed. The live record began on 2026-09-11. Years 2021 through 2026 are sealed in the store but are not served as of a date; the as-of door answers not_sealed.

Sources

10 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1

https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)

10.2

https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/IMM (identity.isin)

10.3

https://find-and-update.company-information.service.gov.uk/company/03929567 (identity.jurisdiction)

10.4

https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)

10.5

https://www.londonstockexchange.com/stock/IMM/immupharma-plc/company-page (identity.sector)

10.6

https://mcp.uk-cm-kg.ai/events/AIM/IMM (the disclosure lines)

10.7

https://marketsecurities.fca.org.uk/officiallist (the halt flag)

10.8

https://www.immupharma.co.uk/wp-content/uploads/2025/10/IMM-Final-Report-Accounts-end-Dec-2024-1.pdf (the auditor)

10.9

https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)

10.10

https://mcp.uk-cm-kg.ai/record/AIM/IMM (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"GB0033711010"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:af28c124a5fb02c7.